Publication | Closed Access

PEGylated lipid bilayer-supported mesoporous silica nanoparticle composite for synergistic co-delivery of axitinib and celastrol in multi-targeted cancer therapy

NanoparticlesNanomedicineEngineeringNanomaterialsPolymer-drug ConjugateTherapeutic NanomaterialsSynergistic Co-deliveryNano-drug DeliveryMulti-targeted Cancer TherapyBiomedical Engineering